Search

Your search keyword '"Izbicki, Jakob Robert"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Izbicki, Jakob Robert" Remove constraint Author: "Izbicki, Jakob Robert"
159 results on '"Izbicki, Jakob Robert"'

Search Results

10. Risk Factor Analysis for Developing Major Complications Following Esophageal Surgery—A Two-Center Study.

11. Solid-pseudopapilläre Neoplasien des Pankreas

14. FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas

18. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

19. Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma

25. Solid-pseudopapilläre Neoplasien des Pankreas

28. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer

30. RAI3 is overexpressed in gastric adenocarcinoma but unrelated to prognosis

32. C-Reactive Protein in the Prediction of Localization of Gastrointestinal Perforation.

35. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

36. Arbeitsorganisation in Behandlungs-Teams

40. Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

41. The role of RANK-signaling in tumor cell proliferation and migration in pancreatic adenocarcinoma.

43. High mitochondria content is associated with prostate cancer disease progression

44. C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC

45. The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer

46. LigaSure™ Vs. Conventional Dissection Techniques in Pancreatic Surgery—a Prospective Randomised Single-Centre Trial

49. Prognostic factors in nonsmall cell lung cancer

50. Reflections on the current staging system for lung cancer

Catalog

Books, media, physical & digital resources